This European pharma company's next three months are catalyst-rich: Bernstein
A British pharmaceutical company faces three major milestones over the next three months that Bernstein says could strengthen the case ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
